BROADWOOD PARTNERS, L.P.
CIK 1278386 · last filed 2026-04-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$982.67M
Companies
8
Total Filings
67
Lifetime Open-Market Net
-$179.07M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. (OCX) Delisted | 10%+ Owner | 24,148,020 | $3.20 | $77.27M | $137.03M | 12 | 2026-04-20 |
| STAA | 10%+ Owner | 30,907,258 | $28.37 | $876.84M | -$233.92M | 30 | 2026-01-13 |
| LCTX | Director | 83,332,510 | $1.27 | $105.83M | $21.00M | 1 | 2024-02-08 |
| Asterias Biotherapeutics, Inc. (AST) Delisted | 10,584,312 | — | — | $12.42M | 1 | 2017-10-18 | |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Director | 30,034,469 | — | — | $22.26M | 4 | 2017-10-17 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | 5,283,320 | — | — | -$149.77M | 3 | 2014-02-13 |
| PALOMAR MEDICAL TECHNOLOGIES LLC (PMTI) Delisted | 10%+ Owner | 5,510,046 | — | — | $8.00M | 2 | 2012-05-31 |
| COMARCO INC (CMRO) Delisted | 10%+ Owner | 2,655,910 | — | — | $3.91M | 12 | 2008-01-22 |
Recent Filings · Page 4 of 7
67 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-12 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Buy (P) | +1,599,999 | $6.00M | EDGAR |
| 2017-10-18 | Asterias Biotherapeutics, Inc. (AST) Delisted | Buy (P) | +4,776,924 | $12.42M | EDGAR |
| 2017-10-17 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Buy (P) | +8,076,921 | $21.00M | EDGAR |
| 2017-08-02 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Buy (P) | +450,000 | $1.26M | EDGAR |
| 2016-05-25 | STAA | Buy (P) | +233,526 | $1.21M | EDGAR |
| 2016-02-09 | STAA | Buy (P) | +275,310 | $1.72M | EDGAR |
| 2016-02-01 | STAA | Buy (P) | +197,949 | $1.28M | EDGAR |
| 2016-01-15 | STAA | Buy (P) | +407,175 | $2.74M | EDGAR |
| 2015-09-29 | STAA | Buy (P) | +933,297 | $6.61M | EDGAR |
| 2014-02-13 | QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Sell (S) | −255,000 | -$17.62M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.